-transparent.png){kind=logo}
We followed the levels of circulating immune complexes (CIC) in 27 patients with Kawasaki disease (KD) from the acute stage of the disease through convalescence, using the test for platelet-reactive IgG-IC, and C1q-binding and conglutinin-binding enzyme immunoassays. CIC were detected by one or more techniques in all but one patient. Positive results were obtained most often with the test for platelet-reactive IgG-IC. Measurement of complement components C3 and C4 in 14 patients revealed an increase in C3 levels during the first few weeks of the disease and normal levels of C4. The blood platelet count correlated directly with the level of platelet-reactive IgG-IC. The highest levels of CIC were found during weeks 3 through 7 after the onset of disease. Measurement of CIC is, however, not applicable to the clinical follow-up of patients with KD.
E Salo, and
R Kekomäki, and
P Pelkonen, and
O Ruuskanen, and
M Viander, and
O Wagner
January 1987,
Progress in clinical and biological research,
E Salo, and
R Kekomäki, and
P Pelkonen, and
O Ruuskanen, and
M Viander, and
O Wagner
December 1984,
Japanese circulation journal,
E Salo, and
R Kekomäki, and
P Pelkonen, and
O Ruuskanen, and
M Viander, and
O Wagner
January 1985,
Pediatric infectious disease,
E Salo, and
R Kekomäki, and
P Pelkonen, and
O Ruuskanen, and
M Viander, and
O Wagner
March 1979,
Archives of disease in childhood,
E Salo, and
R Kekomäki, and
P Pelkonen, and
O Ruuskanen, and
M Viander, and
O Wagner
April 1985,
The Journal of pediatrics,
E Salo, and
R Kekomäki, and
P Pelkonen, and
O Ruuskanen, and
M Viander, and
O Wagner
January 2022,
International immunopharmacology,
E Salo, and
R Kekomäki, and
P Pelkonen, and
O Ruuskanen, and
M Viander, and
O Wagner
October 1989,
Zhonghua yi xue za zhi,
E Salo, and
R Kekomäki, and
P Pelkonen, and
O Ruuskanen, and
M Viander, and
O Wagner
January 2019,
Frontiers in immunology,
E Salo, and
R Kekomäki, and
P Pelkonen, and
O Ruuskanen, and
M Viander, and
O Wagner
January 1984,
Arerugi = [Allergy],
E Salo, and
R Kekomäki, and
P Pelkonen, and
O Ruuskanen, and
M Viander, and
O Wagner
January 1993,
Neoplasma,
